Brand name for Fentanyl
Sublimaze, Duragesic (transdermal formulation)
Drug Class
Opioids. Fentanyl is a synthetic opioid agonist belonging to the phenylpiperidine class
Mechanism of Action
Fentanyl binds to mu receptors in the CNS and spinal cord. Binds to Gi protein -> inhibits adenylate cyclase -> decreases cAMP -> closes voltage gated calcium channels presynaptically and closes K channels post synaptically causing neuronal hyperpolarization
Receptors and physiologic effects
Mu receptor activation.
Mu 1- Supraspinal analgesiaBradycardiaSedationPruritusNausea and vomiting
Mu 2 - Respiratory depressionEuphoriaPhysical dependencePruritusConstipation
Indications
pre/intra/postop analgesia, monitored anesthesia care (MAC), blunting SNS response to intubation/surgical stress
MAC sparing effect of Fentanyl
Administration of 1-2mcg/kg of Fentanyl decreases inhalational anesthetic and propofol requirements by 50%
Potency of Fentanyl
100 times more potent then morphine
Fentanyl: General pharmacokinetics (VD, protein binding, keo)
Fentanyl is highly lipophilic and has a high VD. Rapidly penetrates the BBB.
It is highly protein bound (79-87%).
About 75% of fentanyl undergoes 1st pass pulmonary uptake.
High keo compared to morphine, effect-site equilibration time is 6.4 minutes
Fentanyl: Metabolism
Extensive hepatic metabolism.
N-demethylation via CYP3A4.
Metabolites have minimal pharmacologic activity
Fentanyl: primary elimination route
Renal excretion of metabolites.
Elimination half life
Short CLINICAL duration (10-20min)
Fentanyl actually has a long elimination half life due to its large Vd/extensive tissue binding.
Fentanyl: context sensitive half time
After over 2 hours of infusion context sensitive half time largely increases
Special populations
Elderly- elimination half-time increases (due to reduced hepatic clearance, and higher fat)
Patients on any CYP3A4 inhibitors
Fentanyl: side effects
Respiratory depression, decreased CO2 responsiveness
bradycardia
(no histamine release)
sedation, analgesia, euphoria
pruritis, nausea and vomiting, constipation, contraction of sphincter of oddi, miosis
Chest wall rigidity
Contraindications/caution in
patients with OSA.
Premature neonates and elderly = more sensitive
Transfers through placenta and breast milk.
Opioid dependence.
Allergies.
Dosing
1-2mcg/kg for induction